These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8079356)

  • 1. Measurement of botulinum toxin activity: evaluation of the lethality assay.
    Pearce LB; Borodic GE; First ER; MacCallum RD
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):69-77. PubMed ID: 8079356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative determination of biological activity of botulinum toxins utilizing compound muscle action potentials (CMAP), and comparison of neuromuscular transmission blockage and muscle flaccidity among toxins.
    Torii Y; Goto Y; Takahashi M; Ishida S; Harakawa T; Sakamoto T; Kaji R; Kozaki S; Ginnaga A
    Toxicon; 2010; 55(2-3):407-14. PubMed ID: 19778548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic toxicity of botulinum toxin by intramuscular injection in the monkey.
    Scott AB; Suzuki D
    Mov Disord; 1988; 3(4):333-5. PubMed ID: 3211180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of eels (Anguilla anguilla) and carp (Cyprinus carpio) to type C and E botulinum toxin.
    Haagsma J
    Zentralbl Bakteriol Orig A; 1975 Jan; 230(1):59-66. PubMed ID: 1179868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assay in mice for low levels of Clostridium botulinum toxin.
    Takahashi M; Kameyama S; Sakaguchi G
    Int J Food Microbiol; 1990 Dec; 11(3-4):271-7. PubMed ID: 2149278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The median paralysis unit: a more pharmacologically relevant unit of biologic activity for botulinum toxin.
    Pearce LB; Borodic GE; Johnson EA; First ER; MacCallum R
    Toxicon; 1995 Feb; 33(2):217-27. PubMed ID: 7597725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of polyclonal antibodies in mice against cobratoxin, botulinum toxin and ricin without altering their toxicity or use of adjuvant.
    Lipps BV
    J Nat Toxins; 2001 Feb; 10(1):27-32. PubMed ID: 11288726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to botulinum toxin F in seronegative botulinum toxin A--resistant patients.
    Greene PE; Fahn S
    Mov Disord; 1996 Mar; 11(2):181-4. PubMed ID: 8684389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections.
    Borodic GE; Ferrante R; Pearce LB; Smith K
    Mov Disord; 1994 Jan; 9(1):31-9. PubMed ID: 8139603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis.
    Shaari CM; Sanders I
    Muscle Nerve; 1993 Sep; 16(9):964-9. PubMed ID: 8355728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of botulinum toxin.
    Huang W; Foster JA; Rogachefsky AS
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):249-59. PubMed ID: 10906647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum type A toxin neutralisation by specific IgG and its fragments: a comparison of mouse systemic toxicity and local flaccid paralysis assays.
    Jones RG; Alsop TA; Hull R; Tierney R; Rigsby P; Holley J; Sesardic D
    Toxicon; 2006 Sep; 48(3):246-54. PubMed ID: 16870221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of potency of neutralizing antibodies to botulinum toxin using compound muscle action potential (CMAP).
    Torii Y; Takahashi M; Ishida S; Goto Y; Nakahira S; Harakawa T; Kaji R; Kozaki S; Ginnaga A
    Toxicon; 2010; 55(2-3):662-5. PubMed ID: 19781565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessment?
    Wohlfarth K; Sycha T; Ranoux D; Naver H; Caird D
    Curr Med Res Opin; 2009 Jul; 25(7):1573-84. PubMed ID: 19463043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histology and function of the internal anal sphincter after injection of botulinum toxin.
    Langer JC; Birnbaum EE; Schmidt RE
    J Surg Res; 1997 Dec; 73(2):113-6. PubMed ID: 9441803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The botulinum toxin LD50 potency assay - another chapter, another mystery.
    Pickett A
    Altern Lab Anim; 2012 Sep; 40(4):221-3. PubMed ID: 23067303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial neurophysiological studies of intramuscular botulinum-A toxin in humans.
    Hamjian JA; Walker FO
    Muscle Nerve; 1994 Dec; 17(12):1385-92. PubMed ID: 7969239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extraction and concentration of Clostridium botulinum toxins from specimens (author's transl)].
    Sonnenschein B; Bisping W
    Zentralbl Bakteriol Orig A; 1976 Mar; 234(2):247-59. PubMed ID: 5836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies.
    Sharma SK; Ferreira JL; Eblen BS; Whiting RC
    Appl Environ Microbiol; 2006 Feb; 72(2):1231-8. PubMed ID: 16461671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.